SHAH, M. K.; SHAH, M. A.; SHAH, S. D. Risk of hypertension with bevacizumab, an antibody against vascular endothelial growth factor A: a systematic review and meta-analysis. International Journal of Basic & Clinical Pharmacology, [S. l.], v. 8, n. 10, p. 2354–2360, 2019. DOI: 10.18203/2319-2003.ijbcp20194287. Disponível em: https://www.ijbcp.com/index.php/ijbcp/article/view/3735. Acesso em: 5 may. 2024.